Find Reports
Select Report Type
Reimbursement Review
Displaying 1251 - 1258 of 1258
Health Technology Review
Displaying 576 - 589 of 589
Horizon Scan
Displaying 101 - 111 of 111
Projects in Progress
Displaying 26 - 40 of 40
View All Reports
Displaying 1776 - 1800 of 2093
Please scroll or swipe to the right to view the full content.
Title | Description | Files | Last Updated Sort ascending | Project Line | Project Sub Line | Status | Project Number |
---|---|---|---|---|---|---|---|
Saxagliptin + metformin | Reimbursement Review | Withdrawn | SR0336-000 | ||||
Canagliflozin | Reimbursement Review | Withdrawn | SR0335-000 | ||||
Somatropin | Reimbursement Review | Complete | SR0332-000 | ||||
Somatropin | Reimbursement Review | Complete | SR0333-000 | ||||
Somatropin | Reimbursement Review | Complete | SR0334-000 | ||||
Ingenol mebutate | Reimbursement Review | Complete | SR0330-000 | ||||
Lurasidone | Reimbursement Review | Complete | SR0331-000 | ||||
Rivaroxaban | Reimbursement Review | Complete | SR0327-000 | ||||
Ulipristal acetate | Reimbursement Review | Complete | SR0326-000 | ||||
Afinitor for Advanced Breast - Details | Reimbursement Review | Complete | PC0014-000 | ||||
Velcade for Multiple Myeloma - Details | Reimbursement Review | Complete | PC0016-000 | ||||
Inlyta for metastatic renal cell carcinoma (mRCC) - Details | Reimbursement Review | Complete | PC0013-000 | ||||
Dabigatran etexilate | Reimbursement Review | Complete | SF0320-000 | ||||
Rivaroxaban | Reimbursement Review | Complete | SF0321-00 | ||||
Interferon beta-1a | Reimbursement Review | Complete | SR0298-000 | ||||
Everolimus | Reimbursement Review | Complete | SR0315-000 | ||||
Perampanel | Reimbursement Review | Complete | SR0316-000 | ||||
Azilsartan medoxomil | Reimbursement Review | Complete | SR0317-000 | ||||
Azilsartan medoxomil + chlorthalidone | Reimbursement Review | Complete | SR0318-000 | ||||
Mirabegron | Reimbursement Review | Withdrawn | SR0319-000 | ||||
Zolpidem tartrate | Reimbursement Review | Complete | SR0314-000 | ||||
Treanda for Chronic Lymphocytic Leukemia (First Line) | Reimbursement Review | Complete | PC0011-000 | ||||
Telaprevir | Reimbursement Review | Complete | SF0311-000 | ||||
Boceprevir | Reimbursement Review | Complete | SF0312-000 | ||||
Adalimumab | Reimbursement Review | Complete | SR0308-000 |